Related Experiment Video
Updated: May 24, 2025

11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
22.2K
Delayed Normal Pressure Hydrocephalus after Deep Brain Stimulation in Parkinson's Disease.
Sruthi Kola1, Madhavi Karri1, Sumaiya Sehrish2
1Parkinson's Disease and Movement Disorders Research Centre, Hyderabad, India.
Movement Disorders Clinical Practice
|March 5, 2025
Summary
Normal pressure hydrocephalus (NPH) can occur years after deep brain stimulation (DBS) for Parkinson's disease. Early recognition and treatment with shunts can significantly improve patient symptoms.
Area of Science:
- Neurology
- Neurosurgery
Background:
- Deep brain stimulation (DBS) of the subthalamic nuclei (STN) or globus pallidus internus (GPi) is effective for Parkinson's disease (PD) and dystonia.
- While acute complications of DBS are known, delayed complications like normal pressure hydrocephalus (NPH) have not been previously reported.
Observation:
- A case series identified seven Parkinson's disease patients who developed NPH an average of 10.9 years after undergoing DBS (6 STN, 1 GPi).
- These patients presented with cognitive decline and gait disturbances, classic symptoms of NPH.
Findings:
- Imaging studies confirmed hydrocephalus meeting NPH criteria (Radscale >4) in these patients.
- Cerebrospinal fluid (CSF) tap tests further validated the NPH diagnosis.
- Treatment with ventriculoperitoneal shunt placement resulted in significant improvement of NPH symptoms.
Implications:
- This study highlights the importance of considering NPH as a potential delayed complication following DBS in Parkinson's disease patients.
- Early diagnosis and intervention, such as CSF shunting, are crucial for managing NPH and improving functional outcomes in this patient population.
- Further research is warranted to understand the mechanisms linking DBS and the development of NPH.
More Related Videos
Related Concept Videos
Parkinson's Disease: Treatment
182
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
182
Parkinson's Disease: Overview
419
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
419

